Pure Clinicalsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-09-16
Share capital
102,000.00 PLN
Activity description

Pure Clinical is a CRO for the MedTech industry that designs and conducts clinical studies and performance studies for in vitro diagnostic (IVD) devices. It supports manufacturers and distributors with regulatory requirements, certification and product development under the MDR and IVDR, from concept through entry to the European market.

Registered address
Aleje Jerozolimskie 123A, 02-017 Warszawa, Poland
Opening hours
Monday–Friday
9:00–17:00
Phone
Social media
Electronic delivery address
AE:PL-50658-41469-USSWI-24

Financials

Revenue history (in k)

Filing timeliness

1 of 4 financial statements was filed late (for 2022, 4 days late). 2 of 4 audited by a statutory auditor.

  • 202502/07/2026
  • 202415/07/2025
  • 202303/07/2024
  • 202219/07/2023
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.68mMedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD 110.39kMedianUSD 68.58AverageUSD 82.17k
Operating costs
This companyUSD 1.45mMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 1.06mMedianUSD 119.88kAverageUSD 3.90m

Offer

  • Clinical trials
  • Clinical trial design
  • Clinical trial monitoring
  • Clinical data management
  • Clinical evaluation of medical devices
  • Medical device certification
  • Usability testing
Certifications: FSC, ISO 13485, ISO 17025

Website technology

Online shop
  • WooCommerce
Website
  • WordPress
Analytics and marketing
  • Google Tag Manager

Authorized Representatives

Izabela Chodara – President of the Management Board
Katarzyna Wesołowska – Vice President of the Management Board

Manner of representation

Each member of the management board is independently authorised to make declarations of will on behalf of the company and to represent it.

Ownership

OwnerSharesShare valueStake
969$26,175.0495%
Others
51$1,377.635%

Beneficial owners

Person

Subsidiaries

NameStake
75%

Bank accounts

Registered as a VAT taxpayer on 2021-10-12.

  • mBank
    41 1140 2105 0000 2376 7300 1002
  • mBank
    68 1140 2105 0000 2376 7300 1001
  • mBank
    14 1140 2105 0000 2376 7300 1003

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Brillancesp. z o.o.
Clinchoicesp. z o.o.
MolecureS.A.
Medsource Polskasp. z o.o.
Aurevia Polandsp. z o.o.
Scope FluidicsS.A.
Pikralidasp. z o.o.
Ecoverseasp. z o.o.
MPR Labssp. z o.o.
DR Koziejsp. z o.o. + limited partnership

Change history

DateEvent
2022-06-08Share capital increase
2022-02-10Share capital increase
2022-01-19Address change
2021-09-16Entered in the register

FAQ

Last updated: 2026-07-04